Team

---

Dr. Jitesh Rana is an accomplished pharmaceutical executive with more than two decades of leadership across oncology, rare diseases, neurology, and cardiovascular medicine. His expertise spans the complete drug development lifecycle—from early-phase programs through regulatory approval and commercialization—covering both small molecules and biologics. He has directed global safety and medical affairs teams, delivering strategic guidance in clinical, regulatory, and product lifecycle management.

Vipin is a seasoned systems specialist with expertise in Workday integrations, enterprise applications, and BI/analytics solutions. He supports life-science organizations in implementing and integrating platforms used for medical and clinical-trial data management, helping ensure secure data flows, compliance, and streamlined operations. His cross-domain experience enables biotech teams to deploy scalable digital infrastructure that accelerates R&D and clinical execution.

Dr. Zafar Mahmood holds a PhD in Immunology with a focus on B cells and has clinical experience across multiple therapeutic areas. As a Global Clinical & Biomarker Lead, he applies his immunology background and expertise in precision medicine to develop and execute clinical & biomarker strategies for global-phase clinical trials (I-IV) in immunology, immuno-oncology, and rheumatology (primarily arthritis). He has years of experience leading cross-functional teams, vetting technologies, and generating impactful, innovative data for the global phase.

Dr. Arti Pal is a bioscientist specializing in extracellular vesicles (EVs), bioprocess technologies, and plant-based biology. As an entrepreneur, she plays a key role in developing EV products and processes, facilitating the application of emerging scientific findings across clinical and non-clinical (cosmetic) settings. At PCG, Arti advises clients on EV platform strategies, bioprocess scaling, and commercialization planning.

Dr. Anjali Singh is a scientist with expertise in Cell and Gene Therapy (CGT) manufacturing and process scale-up. Her work spans supporting process and analytical control strategies, as well as comparability strategies for regulatory filings, advancing products from lead optimization through scale-up and clinical readiness. At PCG, Anjali advises clients on CMC strategy, technical due diligence, and development pathways to support efficient, streamlined commercialization.